Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.
Saved in:
| Title: | Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus. |
|---|---|
| Authors: | Sathe AG; Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA., Mishra U; Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA., Ivaturi V; Center for Translational Medicine, University of Maryland, Baltimore, Maryland, USA., Brundage RC; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA., Cloyd JC; Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA., Elm JJ; Department of Public Health Science, Medical University of South Carolina, Charleston, South Carolina, USA., Chamberlain JM; Division of Emergency Medicine, Children's National Hospital and the Department of Pediatrics and Emergency Medicine, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia, USA., Silbergleit R; Department of Emergency Medicine, University of Michigan, Ann Arbor, Michigan, USA., Kapur J; Department of Neurology and Department of Neuroscience, Brain Institute, University of Virginia, Charlottesville, Virginia, USA., Lowenstein DH; Department of Neurology, University of California, San Francisco, California, USA., Shinnar S; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA., Cock HR; Clinical Neurosciences Academic Group, Institute of Molecular and Clinical Sciences, St George's University of London, London, UK., Fountain NB; Department of Neurology, Comprehensive Epilepsy Program, Charlottesville, Virginia, USA., Babcock L; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA., Coles LD; Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA. |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2021 Jun; Vol. 61 (6), pp. 763-768. Date of Electronic Publication: 2021 Jan 12. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33336359 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sathe+AG%22">Sathe AG</searchLink>; Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Mishra+U%22">Mishra U</searchLink>; Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Ivaturi+V%22">Ivaturi V</searchLink>; Center for Translational Medicine, University of Maryland, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Brundage+RC%22">Brundage RC</searchLink>; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Cloyd+JC%22">Cloyd JC</searchLink>; Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Elm+JJ%22">Elm JJ</searchLink>; Department of Public Health Science, Medical University of South Carolina, Charleston, South Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Chamberlain+JM%22">Chamberlain JM</searchLink>; Division of Emergency Medicine, Children's National Hospital and the Department of Pediatrics and Emergency Medicine, School of Medicine and Health Sciences, George Washington University, Washington, District of Columbia, USA.<br /><searchLink fieldCode="AU" term="%22Silbergleit+R%22">Silbergleit R</searchLink>; Department of Emergency Medicine, University of Michigan, Ann Arbor, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Kapur+J%22">Kapur J</searchLink>; Department of Neurology and Department of Neuroscience, Brain Institute, University of Virginia, Charlottesville, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Lowenstein+DH%22">Lowenstein DH</searchLink>; Department of Neurology, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Shinnar+S%22">Shinnar S</searchLink>; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.<br /><searchLink fieldCode="AU" term="%22Cock+HR%22">Cock HR</searchLink>; Clinical Neurosciences Academic Group, Institute of Molecular and Clinical Sciences, St George's University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Fountain+NB%22">Fountain NB</searchLink>; Department of Neurology, Comprehensive Epilepsy Program, Charlottesville, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Babcock+L%22">Babcock L</searchLink>; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Coles+LD%22">Coles LD</searchLink>; Center for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220366372%22">Journal of clinical pharmacology</searchLink> [J Clin Pharmacol] 2021 Jun; Vol. 61 (6), pp. 763-768. <i>Date of Electronic Publication: </i>2021 Jan 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0366372 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-4604 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200912700%22">00912700 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33336359 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/jcph.1801 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 763 Titles: – TitleFull: Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sathe AG – PersonEntity: Name: NameFull: Mishra U – PersonEntity: Name: NameFull: Ivaturi V – PersonEntity: Name: NameFull: Brundage RC – PersonEntity: Name: NameFull: Cloyd JC – PersonEntity: Name: NameFull: Elm JJ – PersonEntity: Name: NameFull: Chamberlain JM – PersonEntity: Name: NameFull: Silbergleit R – PersonEntity: Name: NameFull: Kapur J – PersonEntity: Name: NameFull: Lowenstein DH – PersonEntity: Name: NameFull: Shinnar S – PersonEntity: Name: NameFull: Cock HR – PersonEntity: Name: NameFull: Fountain NB – PersonEntity: Name: NameFull: Babcock L – PersonEntity: Name: NameFull: Coles LD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2021 Jun Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1552-4604 Numbering: – Type: volume Value: 61 – Type: issue Value: 6 Titles: – TitleFull: Journal of clinical pharmacology Type: main |
| ResultId | 1 |
